TribsMab CLC, a novel bispecific antibody format solves a manufacturing challenge
Molecular targeted drugs targeting the NIK associated with the differentiation factor from hepatocytes to cholangiocarcinoma
Prediction of the efficacy of cancer immunotherapy using the tumor-targeting activity of T cells in peripheral blood.
Biomarkers for prediction and diagnosis of interstitial pneumonia, a side effect of cancer treatment with immune checkpoint inhibitors
Drosophila models for human PDAC genotype
Original method and hepatocyte reproduced hepatobiliary function
CHRNB2, a novel target for gastric cancer, potentially other tumors
DR6 mAb promotes Sdc1-DR6 dependent immunosuppressive pathway in autoreactive T cells
(Update): Anti-CKAP4 Monoclonal Antibody Obtained
Cell Surface Antigen CD48 as A Novel Molecular Target for Antibody Therapy in Multiple Myeloma
Investment / Co-development Opportunity for Start-up Company
About Bionauts.jp
